How Do You Measure Blood Sugar? Methods Explained

Blood sugar is measured in several ways, each suited to different goals. A fingerstick glucose meter gives you a snapshot of your blood sugar right now, a continuous glucose monitor tracks it around the clock through a tiny sensor under your skin, and a lab test called HbA1c tells your doctor what your average blood sugar has looked like over the past two to three months. Which method matters most depends on whether you need a quick check before a meal, overnight trend data, or a longer-term picture for diagnosis and management.

Fingerstick Glucose Meters

The most familiar method is the handheld blood glucose meter. You prick the side of a fingertip with a lancet, touch the drop of blood to a disposable test strip, and the meter displays a number in seconds. The strip contains an enzyme, usually glucose oxidase or glucose dehydrogenase, that reacts with the glucose in your blood and generates a tiny electrical signal. The meter converts that signal into a concentration, displayed in milligrams per deciliter (mg/dL) in the United States or millimoles per liter (mmol/L) in most other countries.

These meters are designed for self-monitoring at home and are regulated differently depending on the country. In the United States, the FDA sets its own accuracy criteria for over-the-counter blood glucose monitors, which differ from the international ISO 15197 standard used elsewhere.¹ The practical takeaway is that home meters are allowed a margin of error, and two different brands can give you slightly different readings from the same drop of blood. For most day-to-day decisions like adjusting an insulin dose before a meal, that level of accuracy is sufficient.

What Can Throw Off a Fingerstick Reading

Several substances in your blood can interfere with the chemistry on a test strip. One well-documented culprit is vitamin C (ascorbic acid), particularly at the high intravenous doses sometimes given to cancer patients. Testing on three hospital-grade glucose meters found that increasing concentrations of ascorbic acid caused falsely elevated readings on two of the three devices.² A broader evaluation confirmed that ascorbic acid caused dramatic false highs, false lows, or error messages across multiple meter brands.³ Normal dietary amounts of vitamin C are unlikely to cause problems, but if you are receiving high-dose IV vitamin C in a clinical setting, the staff should be aware of this issue.

Another factor is hematocrit, the proportion of red blood cells in your blood. If your hematocrit is unusually low (as in severe anemia) or unusually high (as in polycythemia or dehydration), the reading can drift. Research into correcting for hematocrit interference found that the distortion becomes especially relevant when blood glucose is above about 110 mg/dL and hematocrit drops below 35%.⁴ Uric acid can also skew results. In everyday home testing for someone without extreme lab values, these interferences rarely cause clinically dangerous errors, but they matter in hospital settings where precise glucose control is critical.

Testing From Alternate Body Sites

Some meters are approved for testing on the forearm, palm, or thigh instead of the fingertip. The appeal is obvious: the fingertip has more nerve endings and the repeated pricking gets old fast. But blood reaches your fingertip faster than it reaches your forearm. Studies measuring the time course of glucose changes found a lag between finger and arm readings that varied from person to person in the range of five to twenty minutes.⁵ When your blood sugar is steady, the difference is small. When it is rising or falling quickly, such as right after a meal or during exercise, a forearm reading can be meaningfully behind what is actually happening in your bloodstream. If you suspect you are going low, test on the fingertip.

Continuous Glucose Monitors

A continuous glucose monitor, or CGM, uses a hair-thin sensor filament inserted just under the skin, typically on the back of the upper arm or the abdomen. The sensor sits in the interstitial fluid, the liquid between your cells, and measures glucose there every few minutes. A small transmitter sends the data wirelessly to a receiver, a smartphone app, or an insulin pump.

The key thing to understand about CGM is that it does not measure blood glucose directly. It measures glucose in interstitial fluid, which lags behind blood glucose by a few minutes. One study in healthy fasting adults measured this physiological delay at roughly five to six minutes.⁶ Other research characterizing sensor performance under real-world conditions has described delays in the range of about ten minutes when accounting for sensor processing.⁷ In practical terms, when your blood sugar is changing rapidly, the number on your CGM screen is slightly behind reality. Modern CGM algorithms try to compensate for this by factoring in the rate of change, but it is worth knowing about during situations like treating a low, when you might keep eating because the CGM still shows a dropping number even though your blood sugar has already started to recover.

Real-Time Versus Flash CGM

There are two main categories. Real-time CGM (rtCGM) pushes readings and alerts to your device automatically, warning you if glucose is falling fast or crossing a threshold. Flash CGM, sometimes called intermittently scanned CGM (isCGM), stores the data on the sensor and only shows it when you scan with a reader or phone. In a randomized trial comparing the two in people with type 1 diabetes, those using real-time CGM spent more time in the target glucose range and less time in hypoglycemia during both exercise and daily life.⁸ The proactive alerts are the likely reason: if the CGM can warn you that your sugar is dropping before you feel it, you can act sooner.

How Accurate Are CGMs

CGM accuracy is commonly described using a metric called MARD, or mean absolute relative difference, which measures how far the sensor’s readings are from a reference lab value on average. Lower is better. Current top-tier sensors report single-digit MARDs, meaning they are typically within about 9 to 10 percent of a lab reference. A real-world evaluation of CGM in both critical and noncritical hospital care found that about 97% of CGM-to-point-of-care meter pairs and over 99% of CGM-to-lab pairs fell in clinically acceptable accuracy zones.⁹ A newer analytical framework proposed by the Diabetes Technology Society ties accuracy zones to clinical risk, showing that for every one-percent increase in top-zone data, the MARD drops by roughly a third of a percent.¹⁰ The bottom line is that modern CGMs are accurate enough for most insulin dosing decisions, but a fingerstick confirmation is still wise when a reading seems off or when you are making a high-stakes dosing change.

Lab Blood Draws and Why the Tube Matters

When a doctor orders a fasting blood glucose test, your blood is drawn into a tube and sent to the lab. The lab typically uses an enzymatic method to measure glucose in the plasma. What many people do not realize is that red blood cells in the tube continue consuming glucose after the blood is drawn, a process called glycolysis. If the sample sits at room temperature for too long, the measured glucose will be lower than it actually was at the time of the draw.

This is why the type of collection tube matters. Sodium fluoride (NaF) tubes contain an additive that inhibits glycolysis and keeps glucose stable for hours. One study comparing NaF tubes to plain serum tubes found that 100% of serum samples showed lower glucose values than the matched NaF samples by six hours, with differences reaching nearly 19 mg/dL, enough to potentially cause a missed diabetes diagnosis.¹¹ A separate comparison of multiple tube types confirmed that citrate-based tubes maintained glucose stability the longest, while heparin tubes showed a progressive decline.¹² For you as a patient, the practical point is that a properly handled sample in the right tube gives a more accurate result. If a lab value seems oddly low and does not match your home readings, delayed processing of the sample is one possible explanation.

HbA1c for the Bigger Picture

A single glucose reading is a snapshot. HbA1c, also called glycated hemoglobin, gives you a longer view. It measures the percentage of hemoglobin in your red blood cells that has glucose stuck to it. Because red blood cells live about three months, HbA1c reflects your average blood sugar over that period. An HbA1c of 5.7% or higher suggests prediabetes; 6.5% or higher is a diagnostic threshold for diabetes.

Labs measure HbA1c using techniques like high-performance liquid chromatography (HPLC), which separates hemoglobin types by electrical charge and quantifies them.¹³ The method is well standardized, but it has blind spots. Certain hemoglobin variants can produce misleading results. One example is Hb Tacoma, a variant found in roughly one in a thousand patients at one large hospital, which caused chromatographic HbA1c results to come back about 40% lower than what immunoassay methods measured.¹⁴ That is a massive error, potentially turning a diabetic HbA1c into a normal-looking one depending on the method used.

Conditions that change red blood cell lifespan also distort HbA1c. If you have iron-deficiency anemia (longer-lived red blood cells), your HbA1c may read falsely high. If you have hemolytic anemia or chronic kidney disease (shorter red blood cell survival), it may read falsely low. In these situations, alternatives like fructosamine or glycated albumin can give a more reliable picture of recent glucose control over roughly the past two to four weeks.¹⁵ Your doctor would typically consider these alternatives if your HbA1c results do not match the pattern seen on your meter or CGM.

CGM and Automated Insulin Delivery

One of the most consequential uses of glucose monitoring is in closed-loop insulin delivery systems, sometimes called an artificial pancreas. These pair a CGM sensor with an insulin pump and a control algorithm. The algorithm reads the CGM data, accounts for the current glucose level, the rate and direction of change, and how much insulin is still active from recent doses, then adjusts the pump’s delivery automatically.¹⁶ The CGM is the eyes of this system; without continuous data, the algorithm has nothing to work with.¹⁷

These systems have shifted the daily burden of type 1 diabetes management dramatically. Rather than checking your blood sugar, calculating a dose, and injecting, the pump and sensor work together to keep glucose in range with far less manual intervention. The sensor’s accuracy and reliability are critical here, because a bad reading could lead the algorithm to deliver too much or too little insulin. This is one reason CGM accuracy standards have tightened over the past decade.

Smartwatches and Non-Invasive Devices

If you have seen ads for a smartwatch or wristband that claims to measure blood sugar without a needle or sensor, be skeptical. Several consumer devices have appeared on the market claiming to estimate glucose using light-based (photoplethysmography or PPG) signals through the skin. When one such non-invasive home glucose monitor was formally tested against standard criteria, it failed to meet both FDA and ISO accuracy guidelines.¹⁸ The fundamental problem is that glucose is present in very low concentrations in the blood relative to other molecules, and measuring it optically through skin, fat, and muscle introduces enormous amounts of signal noise.

Research into optical techniques like Raman spectroscopy and near-infrared spectroscopy continues, but reviews of the field consistently point out that tissue variability, temperature changes, hydration, and skin pigmentation all interfere with accurate readings.¹⁹ A truly non-invasive glucose sensor that works reliably has been called one of the longest-standing unsolved problems in biomedical engineering, and nothing on the consumer market today has cracked it. If a device does not require any skin penetration at all, treat its glucose numbers as entertainment, not medical data.

Microneedle Patches and Next-Generation Sensors

A more promising middle ground between painless wearables and traditional CGMs lies in microneedle-based sensors. These use arrays of extremely tiny needles, short enough that they do not reach nerve endings, to access interstitial fluid just below the skin’s surface.²⁰ Some designs extract a small amount of fluid for external analysis; newer versions embed the sensing chemistry directly on the needles so that measurement happens in the skin itself.

One recent prototype used a flexible patch with fluorescent hydrogel-coated microneedles that respond to glucose concentration in real time, aiming to reduce the signal drift and frequent calibration that plague current subcutaneous sensors.²¹ These are still in the research and early clinical stage, not something you can buy yet. But the approach addresses a real limitation of current CGMs: sensor accuracy tends to degrade over the wear period, and calibration against fingerstick readings is sometimes required. If microneedle patches can maintain accuracy without calibration over a full wear cycle, they could simplify monitoring for millions of people.

Cost and Access Gaps

The method you end up using often depends less on what is best and more on what you can get. Fingerstick meters are relatively cheap, but test strips add up fast if you are checking four or more times a day. CGM offers far richer data, but cost remains a significant barrier to its widespread adoption.²² In the United States, insurance coverage for CGM has expanded considerably in recent years, especially for people on insulin, but out-of-pocket costs still vary widely depending on your plan and which sensor brand your insurer prefers.

Disparities in CGM access persist along lines of age, race, ethnicity, insurance type, and care setting.²³ Globally, large parts of the world still rely primarily on occasional lab draws or basic meters because CGM infrastructure and supply chains are not available. Even HbA1c testing, which requires only a single blood sample, is not universally accessible in lower-resource settings, leaving many people with diabetes managed on minimal data.

How Glucose Monitoring Works for Pets

If you have a diabetic cat or dog, you might recognize the routine: a small blood sample, a meter, a test strip. But veterinary glucose monitoring has its own quirks. Veterinary-specific glucometers are calibrated differently for dogs and cats because their blood chemistry differs from humans and from each other. A study comparing canine and feline settings on a veterinary glucometer found that using the wrong species setting introduced a proportional bias for dog samples and a constant positive bias for cat samples, with individual errors as large as roughly 4.4 mmol/L in one dog and 6.2 mmol/L in one cat.²⁴ Those are large enough errors to change treatment decisions. If your vet sends you home with a glucometer, double-check that the species setting matches your pet.

Human meters are sometimes used for pets in a pinch, but they are calibrated for human blood and can give readings that are consistently off, especially in cats. If ongoing home monitoring is part of your pet’s diabetes plan, a veterinary-grade meter is worth the investment.